Science MagazineCRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activityScience MagazineTaking advantages of the distinctive enzymatic properties of CRISPR enzymes, Gootenberg et al. developed an improved nucleic acid detect… Continue reading
Science MagazineField-deployable viral diagnostics using CRISPR-Cas13Science MagazineTaking advantages of the distinctive enzymatic properties of CRISPR enzymes, Gootenberg et al. developed an improved nucleic acid detection technology for multiplexed … Continue reading
Science MagazineField-deployable viral diagnostics using CRISPR-Cas13 | ScienceScience MagazineCRISPR techniques are allowing the development of technologies for nucleic acid detection (see the Perspective by Chertow). Taking advantages of the distinct… Continue reading
Science MagazineField-deployable viral diagnostics using CRISPR-Cas13Science MagazineCRISPR techniques are allowing the development of technologies for nucleic acid detection (see the Perspective by Chertow). Taking advantages of the distinctive enzyma… Continue reading
Science MagazineNext-generation diagnostics with CRISPRScience MagazineThe sentinel discovery that prokaryotes (bacteria and archaea) have heritable adaptive immunity mediated through CRISPR and CRISPR-associated (Cas) proteins has led to transformativ… Continue reading
Science MagazineCRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activityScience MagazineTaking advantages of the distinctive enzymatic properties of CRISPR enzymes, Gootenberg et al. developed an improved nucleic acid detect… Continue reading
Targazyme Presents TZ-102 Cancer Immunotherapy Preclinical Results at the World Orphan Drug CongressGlobeNewswire (press release)CARLSBAD, Calif., April 26, 2018 (GLOBE NEWSWIRE) — Targazyme, Inc. a late clinical-stage biopharmaceutical company develo… Continue reading
Cronkite NewsGene therapy targets incurable diseasesCronkite NewsPHOENIX — Gene therapy could be the key to curing rare and life-threatening diseases but potential negative effects and costs are slowing the fledgling field, experts say. Gene therapy re… Continue reading